Exact Sciences Corporation Share Price Mexican S.E.
Stocks
EXAS *
US30063P1057
Biotechnology & Medical Research
| Market Cap | 20.03B 341B 17.26B 16.18B 14.77B 27.82B 1,914B 27.91B 192B 74.9B 966B 75.19B 73.55B 3,204B | P/E 2024 |
-10.1x | P/E 2025 | -92.2x |
|---|---|---|---|---|---|
| Enterprise Value | 21.6B 368B 18.61B 17.45B 15.93B 30.01B 2,064B 30.1B 207B 80.77B 1,042B 81.08B 79.32B 3,455B | EV / Sales 2024 |
4.4x | EV / Sales 2025 | 6.42x |
| Free-Float |
98.24% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript : Exact Sciences Corporation
| 1 day | -15.23% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -15.23% | +9.18% | - | - | 20.03B | |
| -4.73% | -3.08% | +91.12% | +277.10% | 4.02B | |
| -3.03% | -3.38% | +259.19% | +30.88% | 3.63B | |
| -4.22% | +2.43% | +42.85% | +64.79% | 3.48B | |
| -4.91% | +2.43% | +264.49% | +442.37% | 2.58B | |
| -3.09% | -6.35% | -26.54% | -26.21% | 2.25B | |
| +6.10% | +7.10% | +39.80% | - | 1.59B | |
| +11.76% | +16.89% | +37.38% | +60.22% | 1.18B | |
| -8.24% | -11.11% | +217.36% | -26.30% | 1.14B | |
| -2.87% | +25.09% | +27.90% | +184.74% | 675M | |
| Average | -2.85% | +0.06% | +105.95% | +125.95% | 2.28B | |
| Weighted average by Cap. | -8.80% | -0.51% | +119.33% | +142.28% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.76B 46.99B 2.38B 2.23B 2.03B 3.83B 264B 3.85B 26.44B 10.32B 133B 10.36B 10.13B 441B | 3.25B 55.31B 2.8B 2.62B 2.39B 4.51B 310B 4.53B 31.12B 12.14B 157B 12.19B 11.93B 519B |
| Net income | -1.03B -17.53B -887M -831M -759M -1.43B -98.33B -1.43B -9.86B -3.85B -49.64B -3.86B -3.78B -165B | -208M -3.54B -179M -168M -153M -289M -19.87B -290M -1.99B -778M -10.03B -781M -764M -33.27B |
| Net Debt | 1.74B 29.6B 1.5B 1.4B 1.28B 2.41B 166B 2.42B 16.66B 6.5B 83.84B 6.52B 6.38B 278B | 1.57B 26.75B 1.35B 1.27B 1.16B 2.18B 150B 2.19B 15.05B 5.87B 75.75B 5.9B 5.77B 251B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
